Research and Markets: The Global Chiral Chemicals Market is Expected to Grow at 13.57%...
Research and Markets: The Global Chiral Chemicals Market is Expected to Grow at 13.57% Compounded Annually From 2005 Through 2012 DUBLIN, Ireland--(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/reports/c90580) has announced the addition of Chiral Chemicals to their offering. This market insight report on Chiral Chemicals focuses on the different Methods and Applications of Chiral Chemicals. Various Chiral Chemical preparation and separation methods include Traditional, Asymmetric, Biological and Other. Pharmaceuticals, Agrochemicals, Flavors/Fragrances are the different Chiral Chemical applications discussed. The study provides global market analysis for preparation of Chiral Chemicals by Traditional (Diastereomeric Crystallisation, Chromatography & Chiral Pool), Asymmetric (Synthesis & Catalysis) and Biological (Bio-catalysis & Kinetic Resolution). The study includes estimates and projections for the global Chiral Chemicals market. Projections and estimates figure for geographic regions including North America, Europe, Asia-Pacific, Japan, and Rest of World. The industry is analyzed in US Dollars and includes 279 exclusive exhibits with graphical representations. A total of 358 companies are covered that are engaged in Chiral Chemical R&D, discovery, testing, and supply of products and services. Global Chiral Chemicals market is expected to grow at 13.57% compounded annually from 2005 through 2012. The United States is the leading market while due to the cost advantage and access to the latest technologies, Asia-Pacific and Japan are the fastest growing markets for Chiral Chemicals with a compounded annual growth of 14.8% and 14.6% respectively. Major companies such as Avecia, UK, and Dow Chemical's Chirotech Technology Ltd, in the United States strive to maintain broad portfolios of chiral chemicals and technologies. Due to the emergence of highly sophisticated and complex mechanisms of synthesis and separation of Chiral Chemicals, a number of small, high technology companies have provided a niche for themselves which are primarily for contract or outsource manufacturing. These companies aid large corporations to develop chiral drugs based on their particular products. Companies Mentioned: Accelrys, Inc. (USA) ADMET Technologies (USA) Advanced Chemistry Development, Inc. (ACD/Labs) (Canada) Agilent Technologies, Inc. (USA) AMRI Hungary, Inc. (Hungary) Applied Biosystems Group (USA) Argenta Discovery Ltd. (UK) Aureus Pharma (France) Bayer Technology Services GmbH (Germany) BD Biosciences (USA) Biacore International AB (Sweden) BioFocus DPI (UK) Bio-Rad Laboratories, Inc. (USA) Bridge Pharmaceuticals (USA) Caliper Life Sciences, Inc. (USA) Cellomics, Inc. (USA) Celsis International plc (UK) Cerep SA (France) Charles River Laboratories, Inc. (USA) ChemSilico LLC (The) (USA) Chenomx, Inc. (Canada) CompuDrug International, Inc. (USA) Cyprotex plc (UK) Gene Logic, Inc. (USA) Iconix Pharmaceuticals, Inc. (USA) ID Business Solutions Ltd. (UK) Invitrogen, Inc. (USA) Kendle International, Inc. (USA) Kibron, Inc. (Finland) LHASA Ltd. (UK) MDL Information Systems (USA) Millipore Corporation (USA) Molecular Discovery Ltd. (UK) MultiCASE, Inc. (USA) Noray Bioinformatics S.L. (Spain) Perkin Elmer, Inc. (USA) Pharma Algorithms (Canada) Promega Corporation (USA) Qualyst, Inc. (USA) Ranbaxy Laboratories Ltd. (India) Schrodinger LLC (USA) Simulations Plus, Inc. (USA) Sirius Analytical Instruments Ltd. (UK) Stem Cell Innovations, Inc. (USA) Strand Life Sciences (India) Sygnis Pharm AG (Germany) Tecan AG (Switzerland) Thermo Fisher Scientific, Inc. (USA) Tripos, Inc. (USA) Waters Corporation (USA) Xceleron Ltd. (UK) Countries Covered: North America USA Canada Europe UK Germany France Sweden Finland Italy Rest of Europe Asia-Pacific Japan China India Australia Rest of Asia-Pacific Rest of World For more information visit here. Research and Markets Laura Wood Senior Manager Fax: +353 1 4100 980 press@researchandmarkets.com Copyright Business Wire 2008
© Thomson Reuters 2008 All rights reserved



